InSphero: Assay-Ready 3D Microtissue Models & Services | Organ on a Chip Technology

Scalable 3d Technology • Organ-on-a-Chip Solutions

The Next Best Thing to Human

for Drug Discovery & Safety Testing

3D platforms engineered for

Gain Unrivaled Biological InSight

Liver Disease

Investigate with Confidence

Screen and test efficacy of NASH and Fibrosis drugs with a platform that mimics NAFLD progression in humans.

Diabetes

Discover with Confidence

Conduct type 1 & type 2 diabetes research in a platform that ensures uniform, long-lived islets with robust functionality.

Oncology

Translate with Confidence

Reflect complex 3D tumor microenvironments with tumor, stromal, and immune components.

Toxicology

Predict with Confidence

Detect DILI with twice the sensitivity without sacrificing specificity in mechanistically accurate 3D liver models.

3D InSight™ platforms include everything you need to optimize your investment in 3D in vitro cell technology: physiologically relevant microtissue models, specially formulated media, 3D-optimized assay protocols, expert support from experienced application scientists, and the option to outsource testing to our services team.

Powered by Scalable Akura™ Technology

Watch how we apply our scalable technology and organ-on-a-chip solutions to engineer powerful and flexible 3D in vitro platforms for drug efficacy and safety testing and the study of metabolic disease and cancers.

For Better, Safer Drugs. Faster.

Why Partner with InSphero?

Add the pioneer in 3D cell-based assay solutions and scaffold-free organ-on-a-chip technology to your drug R&D team and see immediate results.

Relevant

Work with 3D platforms precisely engineered to mimic human biology and save you years of model development and assay testing time.

Reliable

Rely on functionally robust, highly standardized microtissue models produced using ISO 9000 quality control processes.

Reproducible

Ensure reproducible data and minimize confounding factors regardless of the scale and complexity of your experiments.

“Addressing complex diseases requires the rare combination of pioneering innovation and biomedical expertise. As our discovery partner, InSphero gives us immediate access to new technologies, such as organ-on-a-chip systems, that provide deep mechanistic insights into complex diseases. They have become part of our research team, committed to helping us find a cure for type 1 diabetes.”

MATTHIAS VON HERRATH, MD

Professor and Director of the Center for Type 1 Diabetes Research
La Jolla Institute of Immunology

Vice President and Senior Medical Officer
Novo Nordisk

Find out how InSphero 3D InSight™ Platforms and Akura™ Technology

can help drive efficient innovation in drug R&D for your organization.

Get Started